176 related articles for article (PubMed ID: 32772456)
61. Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples.
Michel D; Marre E; Hampl W; Roczkos J; Müller S; Hertenstein B; Kern P; Heymer B; Salzberger B; Arasteh K
J Clin Microbiol; 1995 Nov; 33(11):3064-7. PubMed ID: 8576379
[TBL] [Abstract][Full Text] [Related]
62. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
[TBL] [Abstract][Full Text] [Related]
63. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].
Song T; Chen G; Zhang X; Xu Y; Chen J; Wang Y; Ye L; Xu J; Wu D; Miao J
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3135-9. PubMed ID: 25573307
[TBL] [Abstract][Full Text] [Related]
64. [Clinical study of low cytomegalovirus viral load thresholds for preemptive antiviral therapy in hematopoietic cell transplant recipients].
Li L; Wang Y; Yan CH; Huang XJ
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):191-195. PubMed ID: 29518863
[No Abstract] [Full Text] [Related]
65. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.
Boeckh M; Leisenring W; Riddell SR; Bowden RA; Huang ML; Myerson D; Stevens-Ayers T; Flowers ME; Cunningham T; Corey L
Blood; 2003 Jan; 101(2):407-14. PubMed ID: 12393659
[TBL] [Abstract][Full Text] [Related]
66. Letermovir use may impact on the Cytomegalovirus DNA fragmentation profile in plasma from allogeneic hematopoietic stem cell transplant recipients.
Giménez E; Gozalbo-Rovira R; Albert E; Piñana JL; Solano C; Navarro D
J Med Virol; 2024 Mar; 96(3):e29564. PubMed ID: 38506145
[TBL] [Abstract][Full Text] [Related]
67. [The effect of donor cytomegalovirus serological status on the outcome of allogeneic stem cell transplantation].
Liu J; Fu Q; Wang Y; Wang FR; Han W; Ma YR; Yan CH; Han TT; Wang JZ; Wang ZD; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):459-465. PubMed ID: 33906276
[No Abstract] [Full Text] [Related]
68. [The correlation of cytomegalovirus gB genotype with viral DNA load and treatment time in patients with CMV infection after hematopoietic stem cell transplantation].
Wu XJ; Wang Y; Zhu ZL; Xu Y; He GS; Han Y; Tang XW; Fu ZZ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):109-12. PubMed ID: 23611215
[TBL] [Abstract][Full Text] [Related]
69. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
[TBL] [Abstract][Full Text] [Related]
70. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
71. Role of highly sensitive nucleic acid amplification testing for plasma cytomegalovirus DNA load in diagnosis of cytomegalovirus gastrointestinal disease among kidney transplant recipients.
Taksinwarajarn T; Sobhonslidsuk A; Kantachuvesiri S; Thongprayoon C; Cheungpasitporn W; Bruminhent J;
Transpl Infect Dis; 2021 Aug; 23(4):e13635. PubMed ID: 33982825
[TBL] [Abstract][Full Text] [Related]
72. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
[TBL] [Abstract][Full Text] [Related]
73. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
74. Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Lazzarotto T; Chiereghin A; Piralla A; Piccirilli G; Girello A; Campanini G; Gabrielli L; Costa C; Prete A; Bonifazi F; Busca A; Cairoli R; Colombo AA; Zecca M; Sidoti F; Bianco G; Paba P; Perno CF; Cavallo R; Baldanti F;
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1699-1706. PubMed ID: 29545186
[TBL] [Abstract][Full Text] [Related]
75. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.
Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringdén O
Haematologica; 2006 Jan; 91(1):78-83. PubMed ID: 16434374
[TBL] [Abstract][Full Text] [Related]
76. Effect of cytomegalovirus infection on post-transplant hospitalization days among children undergoing allogeneic hematopoietic cell transplantation: A marginal structural model approach.
Li Y; Vader DT; Oganisian A; Boge CLK; Hayes M; Newman A; Olson T; Freedman J; Elgarten CW; Fisher BT
Pediatr Transplant; 2024 Feb; 28(1):e14526. PubMed ID: 37550269
[TBL] [Abstract][Full Text] [Related]
77. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
[TBL] [Abstract][Full Text] [Related]
78. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
79. Torque teno virus-DNA load as individual cytomegalovirus risk assessment parameter upon allogeneic hematopoietic stem cell transplantation.
Spiertz A; Tsakmaklis A; Farowski F; Knops E; Heger E; Wirtz M; Kaiser R; Holtick U; Vehreschild MJGT; Di Cristanziano V
Eur J Haematol; 2023 Dec; 111(6):963-969. PubMed ID: 37772680
[TBL] [Abstract][Full Text] [Related]
80. [A comparative study of the curative effects of cytomegalovirus preemptive therapy in various kinds of hematopoietic stem-cell transplantation].
Zhao XS; Xu LP; Liu DH; Chen YH; Chen H; Zhang XH; Han W; Wang Y; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):476-80. PubMed ID: 19954043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
